SINGAPORE, Dec. 6, 2018 /PRNewswire/ -- Tychan, a clinical-stage biotechnology company based in Singapore, announced today that its first-in-class candidate drug for the treatment of Yellow Fever received investigatory new drug (IND) regulatory approval from Health Sciences Authority...